Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 17, 2025 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at Kidney Week
September 24, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
September 18, 2025 05:36 ET | Source: Research and Markets

Europe Flow Cytometry Research Report 2025: Market to Surpass $2 Billion by 2035 - Expanding Use in Drug Discovery, Translational Research, and Clinical Trials

Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Europe Flow Cytometry Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Europe flow cytometry...
September 03, 2025 04:33 ET | Source: Research and Markets

Flow Cytometry Market Insights, Growth Outlook and Competitive Intelligence 2025-2033 Featuring BD, Danaher, Thermo Fisher Scientific, Agilent Technologies, and Sony Among Others

Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The "Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits),...
August 14, 2025 16:20 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results

Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
August 06, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
July 28, 2025 06:33 ET | Source: Research and Markets

U.S. Androgenetic Alopecia Market Trends Analysis Report 2025-2030 | Pelage Pharmaceuticals' PP405 Breakthrough a New Era in Alopecia Treatment

Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "U.S. Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, Devices), By Sales Channel (Prescriptions,...
April 17, 2025 10:09 ET | Source: Research and Markets

Oral Proteins & Peptides Market Research Report 2025: Semaglutide, Linaclotide, Calcitonin, GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder Forecast to 2029

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- The "Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic...
April 11, 2025 05:08 ET | Source: Research and Markets

Global Organ Transplant Diagnostics Market Expands Amid Rising Chronic Illness and Demand for Non-Invasive Testing

Dublin, April 11, 2025 (GLOBE NEWSWIRE) -- The "Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Application, Technology, Transplant Type, End User, and...
January 31, 2025 05:20 ET | Source: Research and Markets

Spine Biologics Market Research to 2030: Expansion Fueled by Patient Education and Awareness Campaigns, Favorable Reimbursement Policies, and Strategic Alliances and Collaborations

Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Spine Biologics Market by Product, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering.The global spine biologics...